The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: A systematic review and meta-analysis

Biomarkers in Medicine

Volumn 11, Issue 2, 2017, Pages 195-210

  Wang, Yong Hong ^a,b   Deng, Shao Jun ^a   Yang, Yong Dong ^b   Yao, Nan ^a   Zhao, Jian Meng ^a   Min, Guang Tao ^a   Wang, Jun ^a   Xu, Teng Fei ^a   Zhao, Peng Ying ^a   Wang, Hong Peng ^a   Chen, Wei ^a  

^a LANZHOU UNIVERSITY   (China)

^b First People's Hospital of xi'Ning City   (China)

Author keywords

colorectal cancer; meta analysis; platelet counts; prognosis; thrombocytosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SPECIFIC SURVIVAL; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; HAZARD RATIO; HUMAN; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; OVERALL SURVIVAL; PREDICTION; SYSTEMATIC REVIEW; THROMBOCYTE COUNT; THROMBOCYTOSIS; UNIVARIATE ANALYSIS; COLORECTAL NEOPLASMS; COMPLICATION; FACTUAL DATABASE; META ANALYSIS; MORTALITY; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL RATE;

COLORECTAL NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; HUMANS; MULTIVARIATE ANALYSIS; ODDS RATIO; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; THROMBOCYTOSIS;

EID: 85011324184     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm-2016-0214     Document Type: Article

References (57)

1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136(5), 359-386 (2015).
2. Kanavos P, Schurer W. The dynamics of colorectal cancer management in 17 countries. Eur. J. Health Econ. 10, 115-129 (2010).
3. Canadian Cancer Society's Advisory Committee on Cancer Statistics. (2013) Canadian Cancer Statistics 2013. www.cancer.ca//media/cancer.ca/CW/cancer
4. Aranda E, Aparicio J, Alonso V et al. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin. Transl. Oncol. 17(12), 972-981 (2015).
5. Zhang XJ, Liu YG, Shi XJ et al. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta-analysis. Int. J. Surg. 21, 84-91 (2015).
6. Zhang X, Ran YG. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and metaanalysis. Int. J. Clin. Exp. Med. 8(4), 5379-5387 (2015).
7. Men H, Liang C, Yu M. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature. J. Cancer Res. Ther. 11(1), 67-72 (2015).
8. Yu M, Liu L, Zhang BL et al. Pretreatment thrombocytosis as a prognostic factor in women with gynecologic malignancies: a meta-analysis. Asian Pac. J. Cancer Prev. 13(12), 6077-6081 (2012).
9. Wang C, Chen YG, Gao JL et al. Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. Oncol. Lett. 10(2), 754-760 (2015).
10. Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark. Med. 9(4), 327-335 (2015).
11. Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark. Med. 9(6), 617-617 (2015).
12. Gu ML, Yuan CJ, Liu XM et al. Pre-treatment elevated platelet count associates with HER2 overexpression and prognosis in patients with breast cancer. Asian Pac. J. Cancer Prev. 16(13), 5537-5540 (2015).
13. Campos Gomez S, Cruz M, Serrano Ortiz R et al. Pretreatment platelets count levels as a prognostic factor in triple-negative breast cancer in a Hispanic cohort. J. Clin. Oncol. 32(15), Abstract 1115 (2014).
14. Alcindor T, Trutschnigg B, Chaudhury P et al. Is the platelet count a prognostic factor in pancreas cancer and cholangiocarcinoma? Ann. Oncol. 19, 185-185 (2008).
15. Suzuki K, Aiura K, Kitagou M, Hoshimoto S, Takahashi S, Ueda M. Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology 51(57), 847-853 (2004).
16. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann. Surg. Oncol. 23(3), 900-907 (2016).
17. Toiyama Y, Inoue Y, Kawamura M et al. Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int. Surg. 100(2), 199-207 (2015).
18. Neal CP, Cairns V, Jones MJ et al. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Med. Oncol. 32(5), 144 (2015).
19. Kim HJ, Choi GS, Park JS, Park S, Kawai K, Watanabe T. Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: predicting pathologic tumor response and oncologic outcome. Ann. Surg. Oncol. 22(2), 513-519 (2015).
20. Josa V, Krzystanek M, Vass T, Lang T et al. Thrombocytosis of liver metastasis from colorectal cancer as predictive factor. Pathol. Oncol. Res. 21(4), 991-997 (2015).
21. Josa V, Krzystanek M, Eklund AC et al. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Int. J. Surg. 18, 1-6 (2015).
22. Al-Saeed EF, Tunio MA, Al-Obaid O et al. Correlation of pretreatment hemoglobin and platelet counts with clinicopathological features in colorectal cancer in Saudi population. Saudi J. Gastroenterol. 21(1), 58 (2015).
23. Shen LJ, Zhang H, Liang LP et al. Baseline neutrophil-lymphocyte ratio (≥2. 8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Radiat. Oncol. 9, 1-8 (2014).
24. Paik KY, Lee IK, Lee YS, Sung NY, Kwon TS. Clinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients. Cancer Res. Treat. 46(1), 65-73 (2014).
25. Huang L, Chen FJ, Chen YY et al. Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines. Sci. Rep. 4, 5697 (2014).
26. Guo TH, Krzystanek M, Szallasi Z, Szallasi A. Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma. F1000Res. 3, 180-180 (2014).
27. Choi KW, Hong SW, Chang YG et al. Inflammationbased score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients. Ann. Surg. Treat. Res. 86(6), 309-313 (2014).
28. Baranyai Z, Krzystanek M, Josa V et al. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer. Thromb. Haemost. 111(3), 483-490 (2014).
29. Wan S, Lai Y, Myers RE et al. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J. Gastrointest. Cancer 44(3), 293-304 (2013).
30. Oblak I, Velenik V, Anderluh F, Mozina B, Ocvirk J. The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer. Radiol. Oncol. 47(2), 138-144 (2013).
31. Kawai K, Kitayama J, Tsuno NH, Sunami E, Watanabe T. Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer. Int. J. Colorectal Dis. 28(4), 527-535 (2013).
32. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Brit. J. Cancer 109(2), 401-407 (2013).
33. Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World J. Surg. 36(1), 192-200 (2012).
34. Lin MS, Huang JX, Zhu JY, Shen HZ. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis. Hepatogastroenterology 59(118), 1687-1690 (2012).
35. Kaneko M, Nozawa H, Sasaki K et al. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy. Oncology 82(5), 261-268 (2012).
36. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J. Surg. Oncol. 106(7), 887-891 (2012).
37. Cravioto-Villanueva A, Luna-Perez P, Gutierrez-de la Barrera M et al. Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer. Arch. Med. Res. 43(4), 305-311 (2012).
38. Qiu MZ, Yuan ZY, Luo HY et al. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumor Biol. 31(4), 255-260 (2010).
39. Nyasavajjala SM, Runau F, Datta S, Annette H, Shaw AG, Lund JN. Is there a role for pre-operative thrombocytosis in the management of colorectal cancer? Int. J. Surg. 8(6), 436-438 (2010).
40. Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat. Oncol. 5, 47 (2010).
41. Neal CP, Mann CD, Sutton CD et al. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Eur. J. Cancer 45(1), 56-64 (2009).
42. Dajani K, O'Reilly DA, Carino NL, Ghaneh P, Poston G, Wu A. The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg. 2009, 425065 (2009).
43. Leitch EF, Chakrabarti M, Crozier JEM et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Brit. J. Cancer 97(9), 1266-1270 (2007).
44. Kandemir EG, Mayadagli A, Karagoz B, Bilgi O, Turken O, Yaylaci M. Prognostic significance of thrombocytosis in node-negative colon cancer. J. Int. Med. Res. 33(2), 228-235 (2005).
45. Yu I, Chen L, Ruan JY, Chang JT, Cheung WY. Risk and management of venous thromboembolisms in bevacizumabtreated metastatic colorectal cancer patients. Support. Care Cancer 24(3), 1199-1208 (2016).
46. Wells GA, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analysis. Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Canada (2010).
47. Review Manager (RevMan) [Computer Program]. Version 5. 2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration (2012). http://community.cochrane.org/tools/review-production
48. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann. Inter. Med. 127(9), 820-826 (1997).
49. University of York, Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. CRD, University of York , York, UK (2009).
50. Higgins J, Green Sally (Eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5. 1. 0 [updated March 2011]. The Cochrane Collaboration (2011). The Cochrane Library. www.cochrane-handbook.org
51. DerSimonian RL. Meta-analysis in clinical trials. Control. Clin. Trials 7(3), 177-188 (1986).
52. Mantel NH. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 22(4), 719-748 (1959).
53. Nieswandt B, Hafner M, Echtenacher B, Mannel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59(6), 1295-1300 (1999).
54. Peterson JE, Zurakowski D, Italiano JE et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis 15(2), 265-273 (2012).
55. Kisucka J, Butterfield CE, Duda DG et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc. Natl Acad. Sci. USA 103(4), 855-860 (2006).
56. Zou ZY, Liu HL, Ning N, Li SY, Du XH, Li R. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol. Lett. 11(3), 2241-2248 (2016).
57. Zheng DC, Zheng C, Wu J et al. Neutrophil-lymphocyte ratio predicts the prognosis of patients with colorectal cancer: a meta-analysis. Int. J. Clin. Exp. Med. 9(1), 78-90 (2016).